Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe Bruschi, MD, Alberto Canziani, MD, Tiziano Colombo, MD, Alessandro Frigiola, MD, Luigi Martinelli, MD, Lorenzo Menicanti, MD The Annals of Thoracic Surgery Volume 93, Issue 4, Pages 1146-1153 (April 2012) DOI: 10.1016/j.athoracsur.2011.12.031 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Tricuspid valve replacement: temporal distribution of patients, type of implanted prosthesis, and mortality rate. The Annals of Thoracic Surgery 2012 93, 1146-1153DOI: (10.1016/j.athoracsur.2011.12.031) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meyer long-term cumulative survival is shown for the overall population undergoing tricuspid valve replacement. The Annals of Thoracic Surgery 2012 93, 1146-1153DOI: (10.1016/j.athoracsur.2011.12.031) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meyer long-term cumulative survival is shown according to the type of implanted prosthesis (mechanical, solid line; bioprosthesis, dashed line). The Annals of Thoracic Surgery 2012 93, 1146-1153DOI: (10.1016/j.athoracsur.2011.12.031) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Kaplan-Meyer freedom from reoperation (valve thrombosis or structural valve deterioration) is shown according to the type of implanted prosthesis (mechanical, solid line; bioprosthesis, dashed line). The Annals of Thoracic Surgery 2012 93, 1146-1153DOI: (10.1016/j.athoracsur.2011.12.031) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions